Kymera Therapeutics, Inc. (KYMR)
84.64
-1.62
(-1.88%)
USD |
NASDAQ |
May 07, 16:00
84.64
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Research and Development Expense (Annual) : 308.26M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Revolution Medicines, Inc. | 978.68M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Structure Therapeutics, Inc. | 225.85M |